Copyright © 2001 by the European Society of Cardiology.
Letters to the Editor
A reply
South Hospital, Stockholm, Sweden
References
- Reimold SC, Cantillon CO, Friedman PL, Antman EM. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol. 1993;71:558563[CrossRef][Web of Science][Medline]
- Hohnloser SH, Van de Loo A, Baedecker F. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: Prospective comparison of sotalol versus quinidine. J Am Coll Cardiol. 1995;26:852858[Abstract]
- Hohnloser SH, Kuck K-H, Lilienthal J. Rhythm or rate control in atrial fibrillation Pharmacological intervention in atrial fibrillation (PIAF): a randomised trial. Lancet. 2000;356:17891794[CrossRef][Web of Science][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||